Phase 2 Irritable Bowel Syndrome Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Irritable Bowel Syndrome (IBS) according to a specific standard set of medical guidelines called the Rome IV criteria.
- Your IBS is not the type that mainly causes constipation (known as IBS-C).
- Your IBS symptoms are moderate to severe, based on a specific symptom scoring tool (confirm with trial site if unsure of your score).
- You are able and willing to safely have a colonoscopy (a procedure to look inside your bowel).
Who may not be able to join:
- You have a weakened immune system, or you take medications that suppress your immune system.
- You have a serious bowel or other medical condition that means you cannot safely take the bowel-clearing preparation needed before a colonoscopy.
- You have a serious bowel or other medical condition that means you cannot safely have a colonoscopy under mild sedation.
- You currently have active cancer.
- You are pregnant or breastfeeding.
- You have had certain types of abdominal surgery (some surgeries are exceptions — confirm with the trial site which surgeries may or may not affect your eligibility).
- You have a severe mental health condition, or a diagnosed problem with alcohol or drug misuse.
- You have recently started taking probiotics, or have used antibiotics or anti-inflammatory painkillers (such as ibuprofen) within the last 4 weeks.
- You currently use medications known to affect how your bowel moves (with the exception of loperamide).
- You have a diagnosed bleeding disorder.
- You have been diagnosed with an inflammatory bowel disease (such as Crohn's disease or Ulcerative Colitis), coeliac disease, or microscopic colitis.
- You have chronic kidney or liver disease.
- Your blood test shows a very low level of a specific type of white blood cell called neutrophils (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Madhusudan Grover, MBBS, Mayo Clinic
Phone: 507-538-7774
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of responders
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.